New drug trial aims to ease daily struggles of myasthenia gravis
NCT ID NCT06744920
First seen Jun 26, 2026 · Last updated Jul 30, 2026 · Updated 3 times
Summary
This Phase 3 study tests whether remibrutinib can improve daily function in adults with generalized myasthenia gravis, a condition that causes muscle weakness. About 180 participants will receive either the drug or a placebo for 6 months, followed by an open-label phase where everyone gets the drug. The main goal is to see if symptoms and daily activities get better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remibrutinib
- What this could lead to
- If it works, this could provide a new treatment option to control symptoms and improve daily life for people with generalized myasthenia gravis.
- What could go wrong
- This is a Phase 3 trial, but it is still experimental. The drug may not work better than placebo, and side effects are possible. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth
RECRUITINGOrlando, Florida, 32804, United States
-
California Pacific Medical Center
RECRUITINGSacramento, California, 94115, United States
-
Center for Neurological Disorders G
RECRUITINGGreenfield, Wisconsin, 53228-1321, United States
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
-
Dent Neurological Institute
RECRUITINGBuffalo, New York, 14209, United States
-
Fullerton Neuro and Headache Ctr
RECRUITINGFullerton, California, 92835, United States
-
Homestead Assoc In Research Inc
RECRUITINGHomestead, Florida, 33033, United States
-
Honor Health Research Institute
RECRUITINGScottsdale, Arizona, 85258, United States
-
Houston Methodist Hospital
RECRUITINGHouston, Texas, 77030, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Medstar Washington Hospital Center
RECRUITINGWashington D.C., District of Columbia, 20010-2975, United States
-
Michigan State University-Department of Neurology
RECRUITINGEast Lansing, Michigan, 48824, United States
-
Mid Atlantic Epilepsy and Sleep Ctr
RECRUITINGBethesda, Maryland, 20817-1807, United States
-
Neurological Services of Orlando PA
RECRUITINGOrlando, Florida, 32806, United States
-
Neurology Associates PA
RECRUITINGMaitland, Florida, 32751, United States
Contact Email: •••••@•••••
-
Neuromuscular Research Center
RECRUITINGPhoenix, Arizona, 85013, United States
Contact Email: •••••@•••••
-
Novartis Investigative Site
RECRUITINGRosario, Santa Fe Province, 2000, Argentina
-
Novartis Investigative Site
RECRUITINGCaba, C1055AAF, Argentina
-
Novartis Investigative Site
RECRUITINGCapital Federal, C1023AAB, Argentina
-
Novartis Investigative Site
RECRUITINGSan Miguel de Tucumán, T4000AXL, Argentina
-
Novartis Investigative Site
RECRUITINGKogarah, New South Wales, 2217, Australia
-
Novartis Investigative Site
RECRUITINGFitzroy, Victoria, 3065, Australia
-
Novartis Investigative Site
RECRUITINGSouthport, 4215, Australia
-
Novartis Investigative Site
RECRUITINGLeuven, Vlaams Brabant, 3000, Belgium
-
Novartis Investigative Site
RECRUITINGSalvador, Estado de Bahia, 40050-410, Brazil
-
Novartis Investigative Site
RECRUITINGBrasília, Federal District, 70200-730, Brazil
-
Novartis Investigative Site
RECRUITINGCaxias do Sul, Rio Grande do Sul, 95070-560, Brazil
-
Novartis Investigative Site
RECRUITINGPorto Alegre, Rio Grande do Sul, 90035-903, Brazil
-
Novartis Investigative Site
RECRUITINGPorto Alegre, Rio Grande do Sul, 90480-110, Brazil
-
Novartis Investigative Site
RECRUITINGSão Paulo, São Paulo, 05403-000, Brazil
-
Novartis Investigative Site
RECRUITINGEdmonton, Alberta, T6G 2B7, Canada
-
Novartis Investigative Site
RECRUITINGLondon, Ontario, N6A 5W9, Canada
-
Novartis Investigative Site
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
Novartis Investigative Site
RECRUITINGQuébec, Quebec, G1J 1Z4, Canada
-
Novartis Investigative Site
RECRUITINGHefei, Anhui, 230001, China
-
Novartis Investigative Site
RECRUITINGGuangzhou, Guangdong, 510080, China
-
Novartis Investigative Site
RECRUITINGShijiazhuang, Hebei, 50030, China
-
Novartis Investigative Site
RECRUITINGZhengzhou, Henan, 450003, China
-
Novartis Investigative Site
RECRUITINGWuhan, Hubei, 430030, China
-
Novartis Investigative Site
RECRUITINGWuxi, Jiangsu, 214023, China
-
Novartis Investigative Site
RECRUITINGChangchun, Jilin, 130021, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100034, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100730, China
-
Novartis Investigative Site
RECRUITINGQingdao, 266000, China
-
Novartis Investigative Site
RECRUITINGShanghai, 200040, China
-
Novartis Investigative Site
RECRUITINGShanghai, 200080, China
-
Novartis Investigative Site
RECRUITINGBordeaux, 33076, France
-
Novartis Investigative Site
RECRUITINGNice, 06000, France
-
Novartis Investigative Site
RECRUITINGParis, 75013, France
-
Novartis Investigative Site
RECRUITINGParis, 75940, France
-
Novartis Investigative Site
RECRUITINGStrasbourg, 67081, France
-
Novartis Investigative Site
RECRUITINGToulouse, 31059, France
-
Novartis Investigative Site
RECRUITINGKutaisi, 4600, Georgia
-
Novartis Investigative Site
RECRUITINGTbilisi, 0114, Georgia
-
Novartis Investigative Site
RECRUITINGTbilisi, 0144, Georgia
-
Novartis Investigative Site
RECRUITINGFrankfurt am Main, Hesse, 60590, Germany
-
Novartis Investigative Site
RECRUITINGGummersbach, 51643, Germany
-
Novartis Investigative Site
RECRUITINGHamburg, 20246, Germany
-
Novartis Investigative Site
RECRUITINGMünster, 48149, Germany
-
Novartis Investigative Site
RECRUITINGGurugram, Haryana, 122011, India
-
Novartis Investigative Site
RECRUITINGMangalore, Karnataka, 575002, India
-
Novartis Investigative Site
RECRUITINGNashik, Maharashtra, 422005, India
-
Novartis Investigative Site
RECRUITINGNew Delhi, National Capital Territory of Delhi, 110029, India
-
Novartis Investigative Site
RECRUITINGLudhiana, Punjab, 141001, India
-
Novartis Investigative Site
RECRUITINGVellore, Tamil Nadu, 632 004, India
-
Novartis Investigative Site
RECRUITINGHyderabad, Telangana, 500082, India
-
Novartis Investigative Site
RECRUITINGLucknow, Uttar Pradesh, 226007, India
-
Novartis Investigative Site
RECRUITINGBergamo, BG, 24127, Italy
-
Novartis Investigative Site
RECRUITINGOrbassano, TO, 10043, Italy
-
Novartis Investigative Site
RECRUITINGNaples, 80131, Italy
-
Novartis Investigative Site
RECRUITINGChiba, Chiba, 2608677, Japan
-
Novartis Investigative Site
RECRUITINGSapporo, Hokkaido, 0608543, Japan
-
Novartis Investigative Site
RECRUITINGSapporo, Hokkaido, 0630005, Japan
-
Novartis Investigative Site
RECRUITINGNishinomiya, Hyōgo, 6638501, Japan
-
Novartis Investigative Site
RECRUITINGHanamaki, Iwate, 0250082, Japan
-
Novartis Investigative Site
RECRUITINGSendai, Miyagi, 9838520, Japan
-
Novartis Investigative Site
RECRUITINGSuita, Osaka, 5650871, Japan
-
Novartis Investigative Site
RECRUITINGHigashi-Matsuyama, Saitama, 355-0005, Japan
-
Novartis Investigative Site
RECRUITINGKoshigaya, Saitama, 343-8555, Japan
-
Novartis Investigative Site
RECRUITINGShinjuku Ku, Tokyo, 160-0023, Japan
-
Novartis Investigative Site
RECRUITINGFukuoka, 8128582, Japan
-
Novartis Investigative Site
RECRUITINGFukushima, 9601295, Japan
-
Novartis Investigative Site
RECRUITINGHiroshima, 7348551, Japan
-
Novartis Investigative Site
RECRUITINGLublin, Lublin Voivodeship, 20-064, Poland
-
Novartis Investigative Site
RECRUITINGLublin, Lublin Voivodeship, 20-080, Poland
-
Novartis Investigative Site
RECRUITINGKrakow, POL, 31-505, Poland
-
Novartis Investigative Site
RECRUITINGBydgoszcz, Woj Kujawsko Pomorskie, 85-796, Poland
-
Novartis Investigative Site
RECRUITINGBydgoszcz, 85-065, Poland
-
Novartis Investigative Site
RECRUITINGKatowice, 40-689, Poland
-
Novartis Investigative Site
RECRUITINGLodz, 93-113, Poland
-
Novartis Investigative Site
RECRUITINGLublin, 20-410, Poland
-
Novartis Investigative Site
RECRUITINGLublin, 20-701, Poland
-
Novartis Investigative Site
RECRUITINGPoznan, 61-731, Poland
-
Novartis Investigative Site
RECRUITINGRzeszów, 35-323, Poland
-
Novartis Investigative Site
RECRUITINGSkorzewo, 60-185, Poland
-
Novartis Investigative Site
RECRUITINGSzczecin, 71-252, Poland
-
Novartis Investigative Site
RECRUITINGWarsaw, 01-684, Poland
-
Novartis Investigative Site
RECRUITINGWarsaw, 02-172, Poland
-
Novartis Investigative Site
RECRUITINGBrasov, 500283, Romania
-
Novartis Investigative Site
RECRUITINGBucharest, 040215, Romania
-
Novartis Investigative Site
RECRUITINGSibiu, 550245, Romania
-
Novartis Investigative Site
RECRUITINGBelgrade, 11000, Serbia
-
Novartis Investigative Site
RECRUITINGNiš, 18108, Serbia
-
Novartis Investigative Site
RECRUITINGNovi Sad, 21000, Serbia
-
Novartis Investigative Site
RECRUITINGSeoul, Seoul, 03080, South Korea
-
Novartis Investigative Site
RECRUITINGBusan, 49241, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 03722, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 134 727, South Korea
-
Novartis Investigative Site
RECRUITINGSantiago Compostela, A Coruna, 15706, Spain
-
Novartis Investigative Site
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
RECRUITINGBarcelona, 08035, Spain
-
Novartis Investigative Site
RECRUITINGLleida, 25198, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28034, Spain
-
Novartis Investigative Site
RECRUITINGMálaga, 29010, Spain
-
Novartis Investigative Site
RECRUITINGValencia, 46026, Spain
-
Novartis Investigative Site
RECRUITINGKaohsiung City, 833, Taiwan
-
Novartis Investigative Site
RECRUITINGTainan, 704302, Taiwan
-
Novartis Investigative Site
RECRUITINGTaipei, 10002, Taiwan
-
Novartis Investigative Site
RECRUITINGTaipei, 111045, Taiwan
-
Novartis Investigative Site
RECRUITINGTaoyuan, 33305, Taiwan
-
Novartis Investigative Site
WITHDRAWNLondon, NW1 2BU, United Kingdom
-
Novartis Investigative Site
RECRUITINGLondon, SW17 0QT, United Kingdom
-
SFM Clinical Research LLC
RECRUITINGBoca Raton, Florida, 33487, United States
-
UT Health Science Center
RECRUITINGHouston, Texas, 77030, United States
-
Univ Cali Irvine ALS Neuromuscular
RECRUITINGOrange, California, 92868, United States
-
Univ of Cincinnati Medical Center
RECRUITINGCincinnati, Ohio, 45219, United States
-
University Of Southern California
RECRUITINGLos Angeles, California, 90033, United States
-
University of Chicago Medical Centr
RECRUITINGChicago, Illinois, 60637, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
University of WA Division of Cardio
RECRUITINGSeattle, Washington, 98195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at debilitating muscle weakness
- New hope for myasthenia gravis: experimental drug CNP-106 enters human trials
- New hope for myasthenia gravis patients: experimental drug enters phase 2 trial
- New drug trial aims to ease muscle weakness in rare disease
- New shot could ease daily struggles for myasthenia gravis patients
- New study lets myasthenia gravis patients rate their own symptoms on a new drug